0001415889-23-012271.txt : 20230815 0001415889-23-012271.hdr.sgml : 20230815 20230815180943 ACCESSION NUMBER: 0001415889-23-012271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM RICHARD A CENTRAL INDEX KEY: 0001820036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 231176017 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-08152023_100836.xml X0508 4 2023-08-11 0001583107 Theravance Biopharma, Inc. TBPH 0001820036 GRAHAM RICHARD A C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, RESEARCH & DEVELOPMENT 1 Ordinary Shares 2023-08-11 4 S 0 2322 9.99 D 349746 D This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-08-15